- Apheresis equipment, designed for the separation and collection of specific blood components such as plasma, platelets, and leukocytes, is increasingly becoming a critical tool in therapeutic and donation-based procedures across hospitals, blood banks, and research institutions due to its precision, efficiency, and ability to target individual blood elements
- The escalating demand for apheresis equipment is primarily fueled by the rising incidence of chronic and autoimmune diseases, growing use of apheresis in oncology, neurology, and hematology, and an increasing number of blood donations and transfusion procedures requiring component separation
- North America dominates the apheresis equipment market with the largest revenue share of 35.4% in 2024, characterized by advanced healthcare infrastructure, growing awareness of therapeutic apheresis applications, and the presence of leading manufacturers offering technologically advanced systems
- Asia-Pacific is expected to be the fastest growing region in the apheresis equipment market during the forecast period due to rising healthcare investments, an expanding patient population with chronic diseases, and growing government support for blood collection and transfusion services
- Disposable apheresis kits segment dominates the apheresis equipment market with a market share of 72.22% in 2024, driven by its single-use safety, reduced risk of cross-contamination, and growing demand for cost-effective, sterile procedures across hospitals and blood banks
